Antiphospholipid Antibodies in Critically Ill Patients With COVID‐19

OBJECTIVE: Coagulopathy is one of the characteristics observed in critically ill patients with coronavirus disease 2019 (COVID‐19). Antiphospholipid antibodies (aPLs) contribute to coagulopathy, though their role in COVID‐19 remains unclear. This study was undertaken to determine the prevalence and...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Arthritis Rheumatol
Autors principals: Xiao, Meng, Zhang, Yan, Zhang, Shulan, Qin, Xuzhen, Xia, Peng, Cao, Wei, Jiang, Wei, Chen, Huan, Ding, Xin, Zhao, Hua, Zhang, Hongmin, Wang, Chunyao, Zhao, Jing, Sun, Xuefeng, Tian, Ran, Wu, Wei, Wu, Dong, Ma, Jie, Chen, Yu, Zhang, Dong, Xie, Jing, Yan, Xiaowei, Zhou, Xiang, Liu, Zhengyin, Wang, Jinglan, Du, Bin, Qin, Yan, Gao, Peng, Lu, Minya, Hou, Xin, Wu, Xian, Zhu, Huadong, Xu, Yingchun, Zhang, Wen, Li, Taisheng, Zhang, Fengchun, Zhao, Yongqiang, Li, Yongzhe, Zhang, Shuyang
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2020
Matèries:
COVID‐19
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7361932/
https://ncbi.nlm.nih.gov/pubmed/32602200
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/art.41425
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars